Project Details
Description
A Single Cohort Phase 2 Study of Ruxolitinib in Combination with Corticosteroids for the Treatment of Steroid Refractory Acute Graft vs Host Disease
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/16 → 10/30/21 |
Funding
- INCYTE CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.